MAPT and Alzheimer disease: For example, in Alzheimer’s disease (AD) brain, the overall RhoA levels are found to be reduced, while remaining RhoA co-localized with hyperphosphorylated tau in neurofibrillary tangles (Huesa et al., 2010).